XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCKHOLDERS' EQUITY (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
STOCKHOLDERS' EQUITY [Abstract] |
Schedule of Assumptions | The following assumptions were used to determine the fair value of options granted during the three months ended March 31, 2025 and 2024:
| Three Months Ended March 31,
| 2025 |  | 2024
Expected term | 5.5 - 6.3 years |  | 5.5 - 6.3 years
Volatility | 66% |  | 66%
Dividend yield | 0.0 |  | 0.0
Risk-free interest rate | 4.40% |  | 4.29%
Schedule of Option Activity | A summary of the Company’s option activity under the Company’s equity incentive plans and related information is as follows:
|  | Shares |  |  |  | Weighted Average Exercise Price |
Options outstanding, vested and expected to vest at December 31, 2024 |  | 5,141,516 |  |  | $ | 3.90 |
Forfeited |  | (1,101 | ) |  | $ | 1.29 |
Expired |  | (10,480 | ) |  | $ | 4.89 |
Granted |  | 683,720 |  |  | $ | 16.07 |
Exercised |  | (39,173 | ) |  | $ | 6.61 |
Options outstanding, vested and expected to vest at March 31, 2025 |  | 5,774,482 |  |  | $ | 5.32 |
Options exercisable |  | 3,086,687 |  |  | $ | 3.21 |
Schedule of Unvested RSU Activity | The Company’s RSUs generally vest annually over a period of four years for employees and semi-annually over a period of one year for directors. A summary of the Company’s unvested RSU activity and related information is as follows:
|  | Shares |  |  |  | Weighted Average Grant Date Fair Value |
Balance at December 31, 2024 |  | 5,745,990 |  |  | $ | 5.50 |
Granted |  | 1,658,458 |  |  | $ | 16.11 |
Vested |  | (1,455,350 | ) |  | $ | 4.17 |
Forfeited |  | (93,611 | ) |  | $ | 6.64 |
Balance at March 31, 2025 |  | 5,855,487 |  |  | $ | 8.82 |
Schedule of Stock-Based Compensation Expense | Total stock-based compensation expense for all awards granted under the Company’s equity incentive plans for the three months ended March 31, 2025 and 2024 was as follows:
| Three Months Ended March 31,
(in thousands) |  | 2025 |  |  |  | 2024 |
Research and development | $ | 39 |  |  | $ | 17 |
Plasma center operating expenses |  | 77 |  |  |  | 39 |
Selling, general and administrative |  | 3,873 |  |  |  | 1,841 |
Cost of product revenue |  | 635 |  |  |  | 244 |
Total stock-based compensation expense | $ | 4,624 |  |  | $ | 2,141 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in restricted stock units (RSUs). + References No definition available. + Details
Name: | us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration